ABBOTT
ActiveSummary
ABBOTT has been active since 1948 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.10bn and a net result of €369.8m. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 93% of 6,055 sector peers (NACE 46, fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Group and network
Holdings and subsidiaries
9 holdingsHoldings 9
-
100%
-
100%
- ABBOTT MEDICAL BELGIUMsubsidiaryEquity €13.3mResult €3.7m100%
-
100%
-
100%
-
100%
- Abbott Rapid DiagnosticssubsidiaryEquity €6.8mResult €317,389100%
-
100%
-
100%
Stated earlier (1)
An older source named these holdings; newer accounts no longer list them.
-
100%
According to the 2025 annual accounts of ABBOTT and those of the other companies, the acts in the Belgian Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Companies Code and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
1 current directorThe board mandates are listed below; here you explore them as a network.